ENALAPRIL MALEATE/HCTZ DIN 02352923
Health Canada record
| Active ingredient(s) | ENALAPRIL MALEATE 5 MG; HYDROCHLOROTHIAZIDE 12.5 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | C09BA02 ENALAPRIL AND DIURETICS |
| Original market date | 24-Feb-2011 |
| Current status date | 28-Dec-2017 |
| Source | Health Canada DPD |
Establishment licence of the holder
AA Pharma Inc. — licence 101851, currently licensed, last inspection rating C (2023-05-23).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing ENALAPRIL MALEATE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02019884 | APO-ENALAPRIL | APOTEX INC | Tablet | ENALAPRIL MALEATE 5 MG | Marketed |
| 02019892 | APO-ENALAPRIL | APOTEX INC | Tablet | ENALAPRIL MALEATE 10 MG | Marketed |
| 02019906 | APO-ENALAPRIL | APOTEX INC | Tablet | ENALAPRIL MALEATE 20 MG | Marketed |
| 02020025 | APO-ENALAPRIL | APOTEX INC | Tablet | ENALAPRIL MALEATE 2.5 MG | Marketed |
| 02400677 | ENALAPRIL | SANIS HEALTH INC | Tablet | ENALAPRIL MALEATE 10 MG | Marketed |
| 02400685 | ENALAPRIL | SANIS HEALTH INC | Tablet | ENALAPRIL MALEATE 20 MG | Marketed |
| 02400650 | ENALAPRIL | SANIS HEALTH INC | Tablet | ENALAPRIL MALEATE 2.5 MG | Marketed |
| 02400669 | ENALAPRIL | SANIS HEALTH INC | Tablet | ENALAPRIL MALEATE 5 MG | Marketed |
| 02352931 | ENALAPRIL MALEATE/HCTZ | AA PHARMA INC | Tablet | ENALAPRIL MALEATE 10 MG; HYDROCHLOROTHIAZIDE 25 MG | Marketed |
| 02474808 | JAMP ENALAPRIL | JAMP PHARMA CORPORATION | Tablet | ENALAPRIL MALEATE 10 MG | Marketed |
| 02474816 | JAMP ENALAPRIL | JAMP PHARMA CORPORATION | Tablet | ENALAPRIL MALEATE 20 MG | Marketed |
| 02474786 | JAMP ENALAPRIL | JAMP PHARMA CORPORATION | Tablet | ENALAPRIL MALEATE 2.5 MG | Marketed |
| 02474794 | JAMP ENALAPRIL | JAMP PHARMA CORPORATION | Tablet | ENALAPRIL MALEATE 5 MG | Marketed |
| 02459469 | MAR-ENALAPRIL | MARCAN PHARMACEUTICALS INC | Tablet | ENALAPRIL MALEATE 5 MG | Marketed |
| 02459450 | MAR-ENALAPRIL | MARCAN PHARMACEUTICALS INC | Tablet | ENALAPRIL MALEATE 2.5 MG | Marketed |
| 02444798 | MAR-ENALAPRIL | MARCAN PHARMACEUTICALS INC | Tablet | ENALAPRIL MALEATE 20 MG | Marketed |
| 02444771 | MAR-ENALAPRIL | MARCAN PHARMACEUTICALS INC | Tablet | ENALAPRIL MALEATE 10 MG | Marketed |
| 02565285 | NRA-ENALAPRIL | NORA PHARMA INC | Tablet | ENALAPRIL MALEATE 2.5 MG | Approved |
| 02565307 | NRA-ENALAPRIL | NORA PHARMA INC | Tablet | ENALAPRIL MALEATE 10 MG | Approved |
| 02565293 | NRA-ENALAPRIL | NORA PHARMA INC | Tablet | ENALAPRIL MALEATE 5 MG | Approved |
| 02565315 | NRA-ENALAPRIL | NORA PHARMA INC | Tablet | ENALAPRIL MALEATE 20 MG | Approved |
| 02311429 | PRO-ENALAPRIL - 10 | PRO DOC LIMITEE | Tablet | ENALAPRIL MALEATE 10 MG | Marketed |
| 02311402 | PRO-ENALAPRIL - 2.5 | PRO DOC LIMITEE | Tablet | ENALAPRIL MALEATE 2.5 MG | Marketed |
| 02311437 | PRO-ENALAPRIL - 20 | PRO DOC LIMITEE | Tablet | ENALAPRIL MALEATE 20 MG | Marketed |
| 02311410 | PRO-ENALAPRIL - 5 | PRO DOC LIMITEE | Tablet | ENALAPRIL MALEATE 5 MG | Marketed |
| 02363496 | AVA-ENALAPRIL | AVANSTRA INC | Tablet | ENALAPRIL MALEATE 20.0 MG | Cancelled Post Market |
| 02363488 | AVA-ENALAPRIL | AVANSTRA INC | Tablet | ENALAPRIL MALEATE 10.0 MG | Cancelled Post Market |
| 02363461 | AVA-ENALAPRIL | AVANSTRA INC | Tablet | ENALAPRIL MALEATE 5.0 MG | Cancelled Post Market |
| 02363453 | AVA-ENALAPRIL | AVANSTRA INC | Tablet | ENALAPRIL MALEATE 2.5 MG | Cancelled Post Market |
| 02060531 | ENACARD 1.0MG TABLETS FOR DOGS | MERIAL CANADA INC | Tablet | ENALAPRIL MALEATE 1 MG | Cancelled Post Market |
| 02060574 | ENACARD 10.0MG TABLETS FOR DOGS | MERIAL CANADA INC | Tablet | ENALAPRIL MALEATE 10 MG | Cancelled Post Market |
| 02060558 | ENACARD 2.5MG TABLETS FOR DOGS | MERIAL CANADA INC | Tablet | ENALAPRIL MALEATE 2.5 MG | Cancelled Post Market |
| 02060582 | ENACARD 20.0MG TABLETS FOR DOGS | MERIAL CANADA INC | Tablet | ENALAPRIL MALEATE 20 MG | Cancelled Post Market |
| 02060566 | ENACARD 5.0MG TABLETS FOR DOGS | MERIAL CANADA INC | Tablet | ENALAPRIL MALEATE 5 MG | Cancelled Post Market |
| 02338149 | NU-ENALAPRIL | NU-PHARM INC | Tablet | ENALAPRIL MALEATE 10 MG | Cancelled (Unreturned Annual) |
| 02338130 | NU-ENALAPRIL | NU-PHARM INC | Tablet | ENALAPRIL MALEATE 5 MG | Cancelled (Unreturned Annual) |
| 02338122 | NU-ENALAPRIL | NU-PHARM INC | Tablet | ENALAPRIL MALEATE 2.5 MG | Cancelled (Unreturned Annual) |
| 02338157 | NU-ENALAPRIL | NU-PHARM INC | Tablet | ENALAPRIL MALEATE 20 MG | Cancelled (Unreturned Annual) |
| 02512718 | PRIVA-ENALAPRIL | PHARMAPAR INC | Tablet | ENALAPRIL MALEATE 10 MG | Cancelled Pre Market |
| 02512696 | PRIVA-ENALAPRIL | PHARMAPAR INC | Tablet | ENALAPRIL MALEATE 5 MG | Cancelled Pre Market |
| 02512688 | PRIVA-ENALAPRIL | PHARMAPAR INC | Tablet | ENALAPRIL MALEATE 2.5 MG | Cancelled Pre Market |
| 02512726 | PRIVA-ENALAPRIL | PHARMAPAR INC | Tablet | ENALAPRIL MALEATE 20 MG | Cancelled Pre Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 20212 | 2017-12-28 | New Drug Submission (NDS) | |
| 11500 | 2010-06-11 | New Drug Submission (NDS) |
International API supply for ENALAPRIL MALEATE
8 valid EDQM Certificates of Suitability from 8 holders. 7 active FDA Drug Master Files.
Request a quote for ENALAPRIL MALEATE/HCTZ